Details of the Drug Formulations

General Information of Drug (ID: DMSEPK8)

Drug Name
Brivaracetam Drug Info
Synonyms Rikelta; UCB-34714; Brivaracetam (USAN/INN)
Indication
Disease Entry ICD 11 Status REF
Complex partial seizure 8A68.0 Approved [1]
Epilepsy 8A60-8A68 Phase 3 [2]
Pain MG30-MG3Z Phase 3 [2]
Cross-matching ID
PubChem CID
9837243
ChEBI ID
CHEBI:133013
CAS Number
357336-20-0
TTD ID
D0CT4D
INTEDE ID
DR0230
ACDINA ID
D00078

Full List of Drug Formulations Containing This Drug

Brivaracetam 75 mg tablet
Company Formulation ID FDA Description
UCB F02717 Anhydrous lactose; Lactose monohydrate; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Betadex; Polyvinyl alcohol, unspecified
------------------------------------------------------------------------------------
Brivaracetam 100 mg tablet
Company Formulation ID FDA Description
UCB F02714 Anhydrous lactose; Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Betadex; Polyvinyl alcohol, unspecified
------------------------------------------------------------------------------------
Brivaracetam 25 mg tablet
Company Formulation ID FDA Description
UCB F02715 Anhydrous lactose; Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Betadex; Polyvinyl alcohol, unspecified
------------------------------------------------------------------------------------
Brivaracetam 50 mg tablet
Company Formulation ID FDA Description
UCB F02716 Anhydrous lactose; Lactose monohydrate; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Talc; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Betadex; Polyvinyl alcohol, unspecified
------------------------------------------------------------------------------------
Brivaracetam 10 mg tablet
Company Formulation ID FDA Description
UCB F02713 Anhydrous lactose; Lactose monohydrate; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Polyethylene glycol 3350; Betadex; Polyvinyl alcohol, unspecified
------------------------------------------------------------------------------------

References

1 2016 FDA drug approvals. Nat Rev Drug Discov. 2017 Feb 2;16(2):73-76.
2 New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels. Curr Neurol Neurosci Rep. 2008 Jul;8(4):345-52.